Retension Pharmaceuticals
RTSN · NASDAQ
$16.18−$0.15 (−0.92%)TodayMarket closed ·
Prev close $16.33
Who owns RTSN
No institutional holdings are reported for Retension Pharmaceuticals.
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $369.60K (2 trades) of RTSN on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Keller Eric L. | Other | 31.37K | — |
| Keller Eric L. | Other | 9.66K | — |
| Keller Eric L. | Award | 255.17K | — |
| Keller Eric L. | Other | 31.37K | — |
| Keller Eric L. | Other | 9.66K | — |
| Keller Eric L. | Buy | 20.80K | $249.60K |
| Sweetnam Paul | Other | 2.64K | — |
| Sweetnam Paul | Other | 4.03K | — |
| Sweetnam Paul | Other | 2.64K | — |
| Sweetnam Paul | Other | 4.03K | — |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.